Aperture Therapeutics
UEI: PHRXQ683Q7S1
Overview
Awardee Type
Parent
Company Description
Aperture Therapeutics is building an innovative drug discovery platform
that embraces the genetic diversity of patients and leverages mechanistic
understanding of protective gene variants in the human population.
Name
Aperture Therapeutics
Website
Headquarters
San Carlos, CA
United States
United States
Most Recent Award
July 2, 2024
Calculating
Federal grant recipient
APERTURE THERAPEUTICS, INC.
(UEI PHRXQ683Q7S1)
is headquartered in San Carlos CA.
The corporation
was founded in August 2022 and
federally registered in
September 2022.
Federal Award Analysis
Aperture Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
APERTURE THERAPEUTICS, INC.
UEI
PHRXQ683Q7S1
Primary NAICS
None Reported
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Assistance Awards
Date Founded
Aug. 16, 2022
Initial Registration
Sept. 6, 2022
Last Registration
March 17, 2025
Registration Activation
March 17, 2025
Registration Expiration
March 13, 2026
Fiscal Year End
December 22
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Reported NAICS
None Reported
Accepts Credit Cards
No